Production (Stage)
D
InterCure Ltd. INCR
$1.52 $0.021.33% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Net Income -- -- -- -- -97.53%
Total Depreciation and Amortization -- -- -- -- -27.90%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -- -- -- -- 116.25%
Change in Net Operating Assets -- -- -- -- -213.15%
Cash from Operations -- -- -- -- -220.21%
Capital Expenditure -- -- -- -- 85.49%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- -235.88%
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- 85.90%
Cash from Investing -- -- -- -- 77.22%
Total Debt Issued -- -- -- -- -88.88%
Total Debt Repaid -- -- -- -- -41.01%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- 16.30%
Cash from Financing -- -- -- -- -257.85%
Foreign Exchange rate Adjustments -- -- -- -- 109.05%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -- -- -- -- -845.36%